Intellectual Property India Publishes Patent Application for Anti-Gprc5d Monoclonal Antibodies And Uses Thereof

MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202347044984 A) filed by Lanova Medicines Development Co. , Ltd. on July 05, 2023, for Anti-Gprc5d Monoclonal Antibodies And Uses Thereof.

Inventors include Li, Runsheng; and Huang, Wentao.

The application for the patent was published on October 02, 2026, under issue no. 40/2026.

Abstract: Provided are antibodies or fragments thereof having binding specificity to the human GPRC5D protein. The antibodies or fragments thereof are capable of targeting cancer cells expressing GPRC5D, and thus can be used to treat the cancer, in particular hematological cancer.

Disclaimer: Curated by HT Syndication.